People at High Risk of Influenza Complications and Thus Recommended for Antiviral Treatment of Suspected or Confirmed Influenza

Children <5 years and especially <2 years
Adults ≥50 years
People with chronic pulmonary (including asthma), cardiovascular (except hypertension alone), renal, hepatic, hematologic (including sickle cell disease), or metabolic disorders (including diabetes mellitus) or neurologic and neurodevelopment conditions (including disorders of the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy [seizure disorders], stroke, intellectual disability, moderate to severe developmental delay, muscular dystrophy, or spinal cord injury)
People with immunosuppression, including that caused by medications or by HIV infection
All women who are pregnant, are considering pregnancy, or are in the postpartum period during the influenza season
People <19 years old who are receiving long-term aspirin therapy
American Indian and/or Alaskan native people
People with extreme obesity (ie, BMI ≥40)
Residents of nursing homes and other chronic care facilities
Hospitalized patients at high risk of influenza complications
  • Adapted from Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 influenza season. MMWR Recomm Rep. 2018;67(3):1–20.